Medicenna Therapeutics Statistics

Total Valuation

Medicenna Therapeutics has a market cap or net worth of 175.49 million. The enterprise value is 140.93 million.

Market Cap	175.49M
Enterprise Value	140.93M

Important Dates

The next estimated earnings date is Tuesday, June 25, 2024.

Earnings Date	Jun 25, 2024
Ex-Dividend Date	n/a

Share Statistics

Medicenna Therapeutics has 74.78 million shares outstanding.

Shares Outstanding	74.78M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	22.05%
Owned by Institutions (%)	7.29%
Float	46.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	204.08
PS Ratio	n/a
Forward PS	n/a
PB Ratio	8.73
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.77

Current Ratio	5.77
Quick Ratio	5.50
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	14.05

Financial Efficiency

Return on equity (ROE) is -82.76% and return on invested capital (ROIC) is -71.36%.

Return on Equity (ROE)	-82.76%
Return on Assets (ROA)	-66.26%
Return on Capital (ROIC)	-71.36%
Revenue Per Employee	n/a
Profits Per Employee	-963,625
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-2.43M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +173.91% in the last 52 weeks. The beta is 1.29, so Medicenna Therapeutics's price volatility has been higher than the market average.

Beta (1Y)	1.29
52-Week Price Change	+173.91%
50-Day Moving Average	1.81
200-Day Moving Average	0.83
Relative Strength Index (RSI)	60.02
Average Volume (30 Days)	180,731

Short Selling Information

The latest short interest is 87,922, so 0.12% of the outstanding shares have been sold short.

Short Interest	87,922
Short Previous Month	136,728
Short % of Shares Out	0.12%
Short % of Float	0.19%
Short Ratio (days to cover)	0.37

Income Statement

Revenue	n/a
Gross Profit	-5,000
Operating Income	-13.29M
Pretax Income	-15.42M
Net Income	-15.42M
EBITDA	-19.00M
EBIT	-19.00M
Earnings Per Share (EPS)	-0.22

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	21.76M
Total Debt	n/a
Net Cash	21.76M
Net Cash Per Share	0.29
Equity / Book Value	18.63M
Book Value Per Share	0.25
Working Capital	19.18M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-13.71M
Capital Expenditures	n/a
Free Cash Flow	-13.71M
FCF Per Share	-0.20

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Medicenna Therapeutics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-9.48%
FCF Yield	-8.42%

Analyst Forecast

Price Target	4.57
Price Target Difference	81.35%
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a